314 related articles for article (PubMed ID: 30992079)
1. Role of MAML1 in targeted therapy against the esophageal cancer stem cells.
Moghbeli M; Mosannen Mozaffari H; Memar B; Forghanifard MM; Gholamin M; Abbaszadegan MR
J Transl Med; 2019 Apr; 17(1):126. PubMed ID: 30992079
[TBL] [Abstract][Full Text] [Related]
2. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
[TBL] [Abstract][Full Text] [Related]
3. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
4. MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1.
Forghanifard MM; Azaraz S; Ardalan Khales S; Morshedi Rad D; Abbaszadegan MR
Mol Biol Rep; 2020 Apr; 47(4):2659-2668. PubMed ID: 32180088
[TBL] [Abstract][Full Text] [Related]
5. Contribution of MAML1 in esophageal squamous cell carcinoma tumorigenesis.
Hashemi Bidokhti M; Abbaszadegan MR; Sharifi N; Abbasi Sani S; Forghanifard MM
Ann Diagn Pathol; 2017 Apr; 27():79-82. PubMed ID: 28325367
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
[TBL] [Abstract][Full Text] [Related]
7. Role of Msi1 and MAML1 in Regulation of Notch Signaling Pathway in Patients with Esophageal Squamous Cell Carcinoma.
Moghbeli M; Forghanifard MM; Sadrizadeh A; Mozaffari HM; Golmakani E; Abbaszadegan MR
J Gastrointest Cancer; 2015 Dec; 46(4):365-9. PubMed ID: 26294058
[TBL] [Abstract][Full Text] [Related]
8. ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.
Tsai ST; Wang PJ; Liou NJ; Lin PS; Chen CH; Chang WC
PLoS One; 2015; 10(11):e0142834. PubMed ID: 26571024
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
[TBL] [Abstract][Full Text] [Related]
10. Role of MAML1 and MEIS1 in Esophageal Squamous Cell Carcinoma Depth of Invasion.
Abbaszadegan MR; Moghbeli M
Pathol Oncol Res; 2018 Apr; 24(2):245-250. PubMed ID: 28462489
[TBL] [Abstract][Full Text] [Related]
11. Detention and Identification of Cancer Stem Cells in Esophageal Squamous Cell Carcinoma.
Islam F; Gopalan V; Lam AK
Methods Mol Biol; 2020; 2129():177-191. PubMed ID: 32056178
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
13. CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
Lun SW; Cheung ST; Cheung PF; To KF; Woo JK; Choy KW; Chow C; Cheung CC; Chung GT; Cheng AS; Ko CW; Tsao SW; Busson P; Ng MH; Lo KW
PLoS One; 2012; 7(12):e52426. PubMed ID: 23285037
[TBL] [Abstract][Full Text] [Related]
14. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor.
Shiozaki A; Kudou M; Ichikawa D; Fujiwara H; Shimizu H; Ishimoto T; Arita T; Kosuga T; Konishi H; Komatsu S; Okamoto K; Marunaka Y; Otsuji E
J Gastroenterol; 2018 Feb; 53(2):197-207. PubMed ID: 28389731
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma.
Geng S; Guo Y; Wang Q; Li L; Wang J
Arch Dermatol Res; 2013 Jan; 305(1):35-47. PubMed ID: 22740085
[TBL] [Abstract][Full Text] [Related]
16. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
[TBL] [Abstract][Full Text] [Related]
17. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
[TBL] [Abstract][Full Text] [Related]
18. Identification of gastric cancer stem cells using the cell surface marker CD44.
Takaishi S; Okumura T; Tu S; Wang SS; Shibata W; Vigneshwaran R; Gordon SA; Shimada Y; Wang TC
Stem Cells; 2009 May; 27(5):1006-20. PubMed ID: 19415765
[TBL] [Abstract][Full Text] [Related]
19. α-Mangostin-encapsulated PLGA nanoparticles inhibit colorectal cancer growth by inhibiting Notch pathway.
Chandra Boinpelly V; Verma RK; Srivastav S; Srivastava RK; Shankar S
J Cell Mol Med; 2020 Oct; 24(19):11343-11354. PubMed ID: 32830433
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines.
Fujiwara D; Kato K; Nohara S; Iwanuma Y; Kajiyama Y
Biochem Biophys Res Commun; 2013 May; 434(4):773-8. PubMed ID: 23602898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
